Summary PharmAthene Inc (PharmAthene) is a pharmaceutical company that develops and commercializes medical counter measures to biological and chemical weapons. The company’s products include recombinant protective antigen anthrax vaccine, human monoclonal antibody antitoxin and recombinant BChE bioscavenger. Its products are used for treatment of anthrax, and nerve agent poisoning. PharmAthene serves in markets of biodefense, US civilian, military, and non-US markets. The company collaborates with various pharma and research companies across the world. It markets its products through its distributors across the world. PharmaAthene is headquartered in Annapolis, Maryland, the US. PharmAthene Inc (PIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented... Research Beam Model: Research Beam Product ID: 2114481 250 USD New
PharmAthene Inc (PIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

PharmAthene Inc (PIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : September   2017
  • Pages : 29
  • Publisher : GlobalData
 
 
 
Summary

PharmAthene Inc (PharmAthene) is a pharmaceutical company that develops and commercializes medical counter measures to biological and chemical weapons. The company’s products include recombinant protective antigen anthrax vaccine, human monoclonal antibody antitoxin and recombinant BChE bioscavenger. Its products are used for treatment of anthrax, and nerve agent poisoning. PharmAthene serves in markets of biodefense, US civilian, military, and non-US markets. The company collaborates with various pharma and research companies across the world. It markets its products through its distributors across the world. PharmaAthene is headquartered in Annapolis, Maryland, the US.

PharmAthene Inc (PIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PharmAthene Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
PharmAthene Inc, Pharmaceuticals & Healthcare, Deal Details 10
Merger 10
Altimmune Merges with PharmAthene in Reverse Merger Transaction 10
Licensing Agreements 12
PharmAthene Enters Into Licensing Agreement With Percivia For PER.C6 Cell Line 12
Equity Offering 13
PharmAthene to Raise Additional USD30 Million in Public Offering of Shares 13
PharmAthene Completes Registered Direct Offering Of US$6.5 Million 14
PharmAthene Inc - Key Competitors 15
PharmAthene Inc - Key Employees 16
PharmAthene Inc - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
May 03, 2017: PharmAthene Reports First Quarter 2017 Financial and Operational Results 18
Mar 14, 2017: PharmAthene Reports Year-End 2016 Financial and Operational Results 19
Nov 04, 2016: PharmAthene Reports Third Quarter 2016 Financial and Operational Results 20
Aug 04, 2016: PharmAthene Reports Second Quarter 2016 Financial and Operational Results 21
May 09, 2016: PharmAthene Reports First Quarter 2016 Financial and Operational Results 23
Mar 11, 2016: PharmAthene Reports Year-End 2015 Financial and Operational Results; Provides Update on Litigation with SIGA 24
Corporate Communications 25
Jul 08, 2016: PharmAthene Receives $20 Million Payment from SIGA to Extend Payment Deadline 25
Legal and Regulatory 26
Nov 16, 2016: PharmAthene Receives Final Payment from SIGA of $83.9 Million 26
Apr 13, 2016: PharmAthene Reports Court Approval of SIGA Reorganization Plan to Exit from Bankruptcy 27
Other Significant Developments 28
Sep 16, 2016: PharmAthene Announces Receipt of Payments from SIGA 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
PharmAthene Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PharmAthene Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PharmAthene Inc, Deals By Therapy Area, 2011 to YTD 2017 8
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Altimmune Merges with PharmAthene in Reverse Merger Transaction 10
PharmAthene Enters Into Licensing Agreement With Percivia For PER.C6 Cell Line 12
PharmAthene to Raise Additional USD30 Million in Public Offering of Shares 13
PharmAthene Completes Registered Direct Offering Of US$6.5 Million 14
PharmAthene Inc, Key Competitors 15
PharmAthene Inc, Key Employees 16
PharmAthene Inc, Subsidiaries 17
List of Figures
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter